These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 29528698)
21. Effects of imperatorin in the cardiovascular system and cancer. Nasser MI; Zhu S; Hu H; Huang H; Guo M; Zhu P Biomed Pharmacother; 2019 Dec; 120():109401. PubMed ID: 31622950 [TBL] [Abstract][Full Text] [Related]
22. Colchicine for the treatment of cardiovascular diseases: old drug, new targets. Andreis A; Imazio M; De Ferrari GM J Cardiovasc Med (Hagerstown); 2021 Jan; 22(1):1-8. PubMed ID: 32858634 [TBL] [Abstract][Full Text] [Related]
23. [The opiate system in the regulation of central hemodynamics]. Lishmanov IuB; Maslov LN Patol Fiziol Eksp Ter; 2003; (1):2-11. PubMed ID: 12652936 [No Abstract] [Full Text] [Related]
25. Highlights in opioid agonists and antagonists. Lauretti GR Expert Rev Neurother; 2006 Apr; 6(4):613-22. PubMed ID: 16623659 [TBL] [Abstract][Full Text] [Related]
26. Long-acting opioids and cardiovascular diseases: Help or hindrance! Mehta A; Patel BM Vascul Pharmacol; 2023 Apr; 149():107144. PubMed ID: 36740214 [TBL] [Abstract][Full Text] [Related]
27. Opioids confer myocardial tolerance to ischemia: interaction of delta opioid agonists and antagonists. Bolling SF; Badhwar V; Schwartz CF; Oeltgen PR; Kilgore K; Su TP J Thorac Cardiovasc Surg; 2001 Sep; 122(3):476-81. PubMed ID: 11547297 [TBL] [Abstract][Full Text] [Related]
28. [Agonists of opioid receptors may aggravate ischemic and reperfusion damages of the heart]. Maslov LN; Barzakh EI; Lishmanov AY; Gorbunov AS; Tsybul'nikov SY; Sementsov AS Patol Fiziol Eksp Ter; 2014; (1):79-84. PubMed ID: 25051688 [TBL] [Abstract][Full Text] [Related]
29. Non-analgesic effects of opioids: peripheral opioid effects on inflammation and wound healing. Stein C; Küchler S Curr Pharm Des; 2012; 18(37):6053-69. PubMed ID: 22747536 [TBL] [Abstract][Full Text] [Related]
30. Leptin and the cardiovascular system - a target for therapeutic interventions. Beltowski J Curr Pharm Des; 2014; 20(4):601-2. PubMed ID: 23688018 [No Abstract] [Full Text] [Related]
31. Evidence from basic research for opioid combinations. Davis MP Expert Opin Drug Discov; 2012 Feb; 7(2):165-78. PubMed ID: 22468917 [TBL] [Abstract][Full Text] [Related]
32. New concepts in opioid analgesia. Stein C Expert Opin Investig Drugs; 2018 Oct; 27(10):765-775. PubMed ID: 30148648 [TBL] [Abstract][Full Text] [Related]
33. Pharmacology of opioids. Martin WR Pharmacol Rev; 1983 Dec; 35(4):283-323. PubMed ID: 6144112 [TBL] [Abstract][Full Text] [Related]
34. Natriuretic Peptides in the Cardiovascular System: Multifaceted Roles in Physiology, Pathology and Therapeutics. Rubattu S; Volpe M Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426320 [TBL] [Abstract][Full Text] [Related]
35. Analysis of natural product regulation of opioid receptors in the treatment of human disease. Badal S; Turfus S; Rajnarayanan R; Wilson-Clarke C; Sandiford SL Pharmacol Ther; 2018 Apr; 184():51-80. PubMed ID: 29097308 [TBL] [Abstract][Full Text] [Related]
36. The neuroprotective role of the brain opioid system in stroke injury. Vaidya B; Sifat AE; Karamyan VT; Abbruscato TJ Drug Discov Today; 2018 Jul; 23(7):1385-1395. PubMed ID: 29501910 [TBL] [Abstract][Full Text] [Related]
37. The Abuse Potential of Prescription Opioids in Humans-Closing in on the First Century of Research. Walsh SL; Babalonis S Curr Top Behav Neurosci; 2017; 34():33-58. PubMed ID: 27356522 [TBL] [Abstract][Full Text] [Related]
38. Opioids and opioid receptors in the enteric nervous system: from a problem in opioid analgesia to a possible new prokinetic therapy in humans. Holzer P Neurosci Lett; 2004 May; 361(1-3):192-5. PubMed ID: 15135926 [TBL] [Abstract][Full Text] [Related]
39. cGMP Signaling in Cardiovascular Diseases: Linking Genotype and Phenotype. Dang TA; Schunkert H; Kessler T J Cardiovasc Pharmacol; 2020 Jun; 75(6):516-525. PubMed ID: 32487847 [TBL] [Abstract][Full Text] [Related]
40. Kallikrein-kinin system as the dominant mechanism to counteract hyperactive renin-angiotensin system. Regoli D; Gobeil F Can J Physiol Pharmacol; 2017 Oct; 95(10):1117-1124. PubMed ID: 28384411 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]